Kirsty Ross Stewart

Stock Analyst at Exane BNP Paribas

(1.18)

# 3,546

Out of 4,408 analysts

Total ratings

50%

Success rate

-11.5%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Kirsty Ross Stewart

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ZLDPF Zealand Pharma A/S	Downgraded: Hold	$140 → $43	$44.70	-4.80%	2	Mar 6, 2026
	STO: SOBI Swedish Orphan Biovitrum AB (publ)	Upgraded: Buy	kr 475.00	$435.00	+9.20%	1	Feb 10, 2026

Zealand Pharma A/S

Mar 6, 2026

Downgraded: Hold

Price Target: $140 → $43

Current: $44.70

Upside: -4.80%

Swedish Orphan Biovitrum AB (publ)

Feb 10, 2026

Upgraded: Buy

Price Target: kr 475.00

Current: $435.00

Upside: +9.20%